6855 — Ascentage Pharma International Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$4.56bn
- HK$5.33bn
- CNY221.98m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1,482 | -675 | -832 | -887 | -933 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 984 | 85.8 | 13.4 | 67.4 | 139 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 11.1 | -47.7 | 186 | 104 | -9.15 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -460 | -610 | -605 | -654 | -726 |
Capital Expenditures | -81.4 | -251 | -437 | -237 | -56.8 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -120 | 144 | -29.9 | -148 | 78.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -201 | -107 | -467 | -385 | 21.9 |
Financing Cash Flow Items | -32.3 | -19.3 | -32.9 | -49.8 | -82.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 442 | 1,040 | 1,781 | 619 | 369 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -218 | 281 | 687 | -361 | -308 |